1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA AL513122.2 CTRPv2 pan-cancer AAC 0.16 4e-05
mRNA SMIM22 CTRPv2 pan-cancer AAC 0.17 4e-05
mRNA AL513122.1 CTRPv2 pan-cancer AAC 0.16 4e-05
mRNA ATP8B4 CTRPv2 pan-cancer AAC 0.15 4e-05
mRNA NUMBL CTRPv2 pan-cancer AAC -0.15 4e-05
mRNA LOXL2 CTRPv2 pan-cancer AAC -0.17 4e-05
mRNA PTK2B CTRPv2 pan-cancer AAC 0.18 4e-05
mRNA RALGDS CTRPv2 pan-cancer AAC 0.16 4e-05
mRNA CD101 CTRPv2 pan-cancer AAC 0.14 4e-05
mRNA ASB3 CTRPv2 pan-cancer AAC -0.15 4e-05
Download CSV